Potential new symptomatic drugs for Alzheimer’s disease

At the 31st International Conference of Alzheimer’s Disease International (ADI), held in Budapest, Hungary, from April 21–24 2016, Serge Gauthier, C.M., MD, FRCPC, from McGill Centre for Studies in Aging, McGill University, Montreal, Canada, reviews promising agents in clinical development for the symptomatic treatment of people with Alzheimer’s disease.

Share this video